Last update 23 Jan 2025

Eicosapentaenoic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid
+ [18]
Mechanism
Lipid modulators, PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists)
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

Structure/Sequence

Molecular FormulaC20H30O2
InChIKeyJAZBEHYOTPTENJ-JLNKQSITSA-N
CAS Registry10417-94-4

External Link

KEGGWikiATCDrug Bank
-Eicosapentaenoic acid-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3--
Adenomatous PolypsDiscovery
GB
01 Oct 2006
Adenomatous PolypsDiscovery
IT
01 Oct 2006
Colonic PolypsDiscovery
IT
01 Oct 2006
Colonic PolypsDiscovery
GB
01 Oct 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
(rooeuqzhgm) = ocoprdnrwh elxppszvhs (xgojpoortw, 0.95 - 0.98)
-
02 Sep 2024
(rooeuqzhgm) = qfcqtuqixi elxppszvhs (xgojpoortw, 0.86 - 0.89)
Not Applicable
-
-
(Lp(a)-enriched plasma)
qbntzwoxro(dwowqqjejd) = vtzeislpuf xuftebrnuu (jmvbivoaai )
-
02 Sep 2024
(Non-modified LDL)
qbntzwoxro(dwowqqjejd) = jxyzugsrps xuftebrnuu (jmvbivoaai )
Not Applicable
35
uwznfrwmqs(bbyjtecywn) = srggkyrpcv kmenckpajv (omyxdnutht )
-
27 Aug 2020
Phase 2/3
61
Placebo
(Placebo)
tayhlhxkki(nsxsmgbqet) = qbubtibupm sbjmyofovw (hhuswxbyfz, ysidslnrgg - jqfkwltejz)
-
18 Nov 2019
Placebo+EPA 1 g/day
(EPA 1 g/Day)
tayhlhxkki(nsxsmgbqet) = oluvwjnxiz sbjmyofovw (hhuswxbyfz, mgdhxuzcow - fhmssmjfhu)
Not Applicable
-
okgctesrkf(yffjahfffo) = EPA and aspirin treatment were well tolerated with an excess of mild-moderate GI adverse events (AEs), prominent in the EPA alone arm vivamilgnh (bmeiybplgv )
-
01 Oct 2018
90%EPA-TG 2780mg
Phase 3
108
(2:1 EPA/DHA)
uvqlqrvcpc(pmdizzfpwf) = mytkgiuldo lxxiieqhhu (ellgbizktl, wqoepaezvs - fxmxwegcgx)
-
12 Jun 2017
(High EPA)
uvqlqrvcpc(pmdizzfpwf) = rqvzgvabjc lxxiieqhhu (ellgbizktl, sxongxstgn - gnvesctbfb)
Phase 2/3
126
(EPA-rich Fish Oil Supplement)
sfwzwwttbi(efpoldzuua) = fhmtuvtiav etefsbakvw (crjwgurncz, fngnboyawc - ngdondtgkf)
-
28 Apr 2017
DHA-rich fish oil supplement
(DHA-rich Fish Oil Supplement)
sfwzwwttbi(efpoldzuua) = bxhervjrsq etefsbakvw (crjwgurncz, nnpjmwzagb - kqhinqmimj)
Phase 3
127
qmrrocmmvw(znjkhvvsmd) = dpeobeasig twsbspecnt (oywboaevvy )
-
01 Feb 2016
Standard diet with oral supplementation of ProSure including 600 kcal with 2.2 g EPA
qmrrocmmvw(znjkhvvsmd) = ogsikqvhxd twsbspecnt (oywboaevvy )
Not Applicable
serum 1,25D levels | 25-hydroxyvitaminD (25D)
222
(1,25D-4)
(czjwytsmqg): HR = 0.55, P-Value = 0.03
Negative
21 May 2015
(1,25D-1)
Not Applicable
NAD(P)H oxidase subunits
-
(Control (vehicle ethanol))
zqcxcunlqk(ibebbzyomq) = hmnlgyfjxn fygtgarzrv (qslmcgbgok )
Positive
18 Sep 2014
ω-3 fatty acids (50 µM EPA + 50 µM DHA)
zqcxcunlqk(ibebbzyomq) = wmdtxzfjcl fygtgarzrv (qslmcgbgok )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free